NCT07335367Phase 2Completed
PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Phase 2
- Sponsor
- Nanfang Hospital, Southern Medical University
- Participants (registry)
- 83
- Start
- January 2026
- Primary completion
- August 2026
- Study completion
- August 2026
- Last registry update
- September 2026
- Countries
- China
Conditions studied: Androgenetic Alopecia (AGA)
Interventions: Injection of PRP combined with Botulinum Toxin Type A into the alopecic area(s), PRP-only injection into the alopecic area
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.